Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Facing the future: challenges and opportunities in adoptive T cell therapy in cancer.

Magalhaes I, Carvalho-Queiroz C, Hartana CA, Kaiser A, Lukic A, Mints M, Nilsson O, Grönlund H, Mattsson J, Berglund S.

Expert Opin Biol Ther. 2019 Aug;19(8):811-827. doi: 10.1080/14712598.2019.1608179. Epub 2019 Apr 30.

PMID:
30986360
2.

Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients.

Ahlén Bergman E, Hartana CA, Johansson M, Linton LB, Berglund S, Hyllienmark M, Lundgren C, Holmström B, Palmqvist K, Hansson J, Alamdari F, Huge Y, Aljabery F, Riklund K, Winerdal ME, Krantz D, Zirakzadeh AA, Marits P, Sjöholm LK, Sherif A, Winqvist O.

Clin Epigenetics. 2018 Aug 3;10(1):102. doi: 10.1186/s13148-018-0536-6.

3.

Neoadjuvant Chemotherapy Reinforces Antitumour T cell Response in Urothelial Urinary Bladder Cancer.

Krantz D, Hartana CA, Winerdal ME, Johansson M, Alamdari F, Jakubczyk T, Huge Y, Aljabery F, Palmqvist K, Zirakzadeh AA, Holmström B, Riklund K, Sherif A, Winqvist O.

Eur Urol. 2018 Dec;74(6):688-692. doi: 10.1016/j.eururo.2018.06.048. Epub 2018 Jul 17.

PMID:
30025882
4.

Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer.

Hartana CA, Ahlén Bergman E, Broomé A, Berglund S, Johansson M, Alamdari F, Jakubczyk T, Huge Y, Aljabery F, Palmqvist K, Holmström B, Glise H, Riklund K, Sherif A, Winqvist O.

Clin Exp Immunol. 2018 Oct;194(1):39-53. doi: 10.1111/cei.13183. Epub 2018 Aug 24.

5.

Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathway.

Hartana CA, Ahlén Bergman E, Zirakzadeh AA, Krantz D, Winerdal ME, Winerdal M, Johansson M, Alamdari F, Jakubczyk T, Glise H, Riklund K, Sherif A, Winqvist O.

PLoS One. 2018 Jul 2;13(7):e0200079. doi: 10.1371/journal.pone.0200079. eCollection 2018.

6.

Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness.

Winerdal ME, Krantz D, Hartana CA, Zirakzadeh AA, Linton L, Bergman EA, Rosenblatt R, Vasko J, Alamdari F, Hansson J, Holmström B, Johansson M, Winerdal M, Marits P, Sherif A, Winqvist O.

Cancer Immunol Res. 2018 May;6(5):528-538. doi: 10.1158/2326-6066.CIR-17-0466. Epub 2018 Mar 27.

7.

Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer.

Zirakzadeh AA, Kinn J, Krantz D, Rosenblatt R, Winerdal ME, Hu J, Hartana CA, Lundgren C, Bergman EA, Johansson M, Holmström B, Hansson J, Sidikii A, Vasko J, Marits P, Sherif A, Winqvist O.

Clin Immunol. 2017 Mar;176:63-70. doi: 10.1016/j.clim.2016.12.003. Epub 2016 Dec 24.

PMID:
28025135
8.

Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours.

Hartana CA, Kinn J, Rosenblatt R, Anania S, Alamdari F, Glise H, Sherif A, Winqvist O.

Br J Cancer. 2016 Oct 11;115(8):957-966. doi: 10.1038/bjc.2016.279. Epub 2016 Sep 6.

Supplemental Content

Loading ...
Support Center